Neuropharmacological review of hypothalamic releasing factors.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004569:Electroencephalography; D000882:Haplorhini; D007031:Hypothalamus / Q000502:physiology*; D008253:Macaca mulatta; D008694:Methamphetamine / Q000037:antagonists & inhibitors; D051379:Mice; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D010905:Pituitary Hormone Release Inhibiting Hormones / Q000494:pharmacology*; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D012640:Seizures / Q000503:physiopathology; D012701:Serotonin / Q000494:pharmacology
D010905:Pituitary Hormone Release Inhibiting Hormones; D010906:Pituitary Hormone-Releasing Hormones; D012701:Serotonin; D008694:Methamphetamine; D010095:Oxotremorine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D001058:Apomorphine